UCLA Training Program on Addiction Medicine in Primary Care

描述（由申请人提供）：本申请旨在建立一个关于加州大学洛杉矶分校初级保健成瘾医学主题的研究培训计划。其基本原理既反映了该计划的重要性，也反映了该领域的最新发展。首先，精神活性物质的问题使用和滥用在初级保健病人中非常普遍，是一种“慢性疾病”。初级保健医生经常在“医疗之家”的范围内管理慢性病，因此，这是一个重要的机会，可以通过初级保健中对成瘾问题的医疗管理来减少成瘾对个人、财政和社会的影响。其次，在过去十年中，有四种治疗类阿片、酒精和尼古丁依赖的药物上市。如何将这些新的和标准的成瘾药物最佳地整合到初级保健中，以改善生活质量，减少患者的痛苦，在证据方面存在重大差距。该培训计划的目标是为医生和行为培训生提供研究，学术培训和指导专业发展，以过渡到独立资助的初级保健成瘾医学新兴研究领域的临床研究人员。该申请汇集了加州大学洛杉矶分校的14名临床研究导师，他们的专业知识涵盖了家庭医学、儿科、普通内科和老年医学。该项目包括一名项目主任，他在初级和专业护理环境中对成瘾药物进行了广泛的临床研究，一名副主任在对代表性不足的人群进行研究方面具有出色的经验，以及一个执行委员会，该委员会由高级教师导师和一名代表组成，提供指导和监督。对培训生的进步和指导质量进行持续评估的计划，以及解决进展中出现的缺陷的纠正措施的程序。描述了一项征聘受训人员的积极计划，包括征聘和保留少数民族调查员的计划。

DESCRIPTION (provided by applicant): This application seeks to establish a research training program on the topic of addiction medicine in primary care at UCLA. The rationale reflects both the significance of the program and recent developments in the field. First, problem use and abuse of psychoactive substances, which is highly prevalent among primary care patients, is one type of "chronic disease." Primary care physicians frequently manage chronic diseases within the context of the "medical home" and as such, represent an important opportunity to reduce personal, fiscal and social impacts of addiction using medical management of addiction problems in primary care. Secondly, four medications have been brought on market for treating opioid, alcohol and nicotine seven dependence over the past decade. There is a significant gap in the evidence describing how these new and standard addiction medications can be optimally integrated into primary care to improve quality of life and to reduce suffering for those afflicted. The goal of this training program is to provide physician and behavioral trainees with the research, academic training and mentored professional development to transition into independently funded clinical researchers in the emerging area of research on the topic of addiction medicine in primary care. The application brings together 14 faculty clinical research mentors at UCLA whose expertise covers the lifespan and includes family medicine, pediatrics, general internal medicine and geriatrics. The program includes a Program Director who has conducted extensive clinical research on addiction medicine in primary and specialty care settings, an Associate Director with outstanding experience in conducting research on under-represented populations and an Executive Committee that provides guidance and oversight that is comprised of senior faculty mentors and a fellow representative. A plan for providing continual evaluation of trainee progress and mentorship quality is described, complete with procedures for corrective action to address deficiencies in progress, should these arise. An energetic plan for the recruitment of trainees is described, including a plan for recruitment and retention of minority investigators.